Genmab — Maj 2020
-
Kåre Schultz mener covid-19 ændrer på hvorledes man sælger medicin på i fremtiden. Færre kilometer og venten fra sælgernes side. Færre salgsomkostninger. Jf Børsen https://borsen.dk/nyheder/virksomheder/kaare-schultz-covid-19-skaber-varig-forandring. Det set up Genmab har arbejdet på
-
5 C25 aktier over 60 % på styrkebarometer. ØU. https://ugebrev.dk/flashnews/investering/fem-c25-over-60-paa-styrkebarometer-staerkest-er-pandora-71/
-
It’s fascinating to see scientists in action and how they stand on each others shoulders. Like this:” The infants of mothers carrying this IgG3 polymorphic variant were found to have an increased protection against malaria, most likely caused by the malaria specific IgG3 antibodies crossing the placental membrane more efficiently as a result of increased binding to FcRn”
-
Et par enkelte mere er der plads til.
-
AlphaValue raises target price on Genmab
to 1902, but keeps reduce rating -
10 minutter til Q&A.
I am wondering if it has anyting to do with Covid-1 research , also since they work together with the Dutch blood bank?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind